Literature DB >> 29377897

The Camden & Islington Research Database: Using electronic mental health records for research.

Nomi Werbeloff1,2, David P J Osborn1,2, Rashmi Patel3,4, Matthew Taylor3,4, Robert Stewart3,4, Matthew Broadbent4, Joseph F Hayes1,2.   

Abstract

BACKGROUND: Electronic health records (EHRs) are widely used in mental health services. Case registers using EHRs from secondary mental healthcare have the potential to deliver large-scale projects evaluating mental health outcomes in real-world clinical populations.
METHODS: We describe the Camden and Islington NHS Foundation Trust (C&I) Research Database which uses the Clinical Record Interactive Search (CRIS) tool to extract and de-identify routinely collected clinical information from a large UK provider of secondary mental healthcare, and demonstrate its capabilities to answer a clinical research question regarding time to diagnosis and treatment of bipolar disorder.
RESULTS: The C&I Research Database contains records from 108,168 mental health patients, of which 23,538 were receiving active care. The characteristics of the patient population are compared to those of the catchment area, of London, and of England as a whole. The median time to diagnosis of bipolar disorder was 76 days (interquartile range: 17-391) and median time to treatment was 37 days (interquartile range: 5-194). Compulsory admission under the UK Mental Health Act was associated with shorter intervals to diagnosis and treatment. Prior diagnoses of other psychiatric disorders were associated with longer intervals to diagnosis, though prior diagnoses of schizophrenia and related disorders were associated with decreased time to treatment.
CONCLUSIONS: The CRIS tool, developed by the South London and Maudsley NHS Foundation Trust (SLaM) Biomedical Research Centre (BRC), functioned very well at C&I. It is reassuring that data from different organizations deliver similar results, and that applications developed in one Trust can then be successfully deployed in another. The information can be retrieved in a quicker and more efficient fashion than more traditional methods of health research. The findings support the secondary use of EHRs for large-scale mental health research in naturalistic samples and settings investigated across large, diverse geographical areas.

Entities:  

Mesh:

Year:  2018        PMID: 29377897      PMCID: PMC5788349          DOI: 10.1371/journal.pone.0190703

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Case registers have been an important component of mental health research since its origins in the late 19th century. The extensive data contained in psychiatric case registers can be used for the development of public health care policy, quality control, epidemiological and service research [1]. Case registers are particularly helpful when investigating the course and outcome of a disorder, as well as allowing intervention response to be evaluated in large, naturalistic samples and settings [2]. Electronic health records (EHRs) have become widely used in UK mental health clinical practice and, therefore, new sources of detailed clinical information are available [3]. EHRs are composed of clinical information captured electronically as structured data as well as data within “free text”. The secondary use of data collected in EHRs can dramatically increase the breadth and depth of information available for research [3, 4]. A case register using EHRs from secondary mental healthcare as source data has the potential to deliver large-scale projects evaluating mental health outcomes in real-world clinical populations, with long follow-up periods. Such studies would otherwise be unfeasible to conduct in terms of time, resource and funding. A mental health case register was developed and implemented in 2008 across South London and Maudsley NHS Foundation Trust (SLaM), a large secondary mental healthcare provider [5]. The Clinical Record Interactive Search (CRIS) is a tool developed by SLAM Biomedical Research Centre (BRC) to enable routinely collected EHRs to be used in research, using an explicit de-identification process [6]. In 2013, funded by National Institute for Health Research (NIHR) D-CRIS programme, the CRIS tool was deployed to four additional Trusts in the UK, including Camden and Islington NHS Foundation Trust (C&I). This paper describes the implementation of CRIS outside SLaM, and tests the feasibility of using a tool developed by one mental healthcare organization in a different mental healthcare setting. The paper describes the C&I Research Database and demonstrates its functioning and capabilities by assessing whether a research project originally conducted on the SLaM case register can be repeated with the same degree of success in a different data source, namely the C&I Research Database. The research project examines time to diagnosis and treatment of bipolar disorder, using applications for identification of diagnoses and medication in free text records.

Materials and methods

Camden and Islington NHS Foundation Trust

C&I is a large mental healthcare provider serving a geographic catchment area of two inner-city London boroughs, and approximately 470,000 residents. Based on social deprivation scores of 326 local authorities in England, Camden is the 74th and Islington is the 14th most deprived local authority [7]. The variation in the levels of deprivation within both boroughs is large, highlighting the inequalities between different population groups and places [8]. Within Camden there are areas that are within the top 10% most deprived areas in England and areas that are in the 20% least deprived [9]. Descriptive data for the two boroughs are summarised in Table 1 and compared with those for London and England. The C&I catchment boroughs do not differ substantially from greater London in terms of the sex distribution, though the proportion of younger people (under the age of 35) is higher in the two boroughs as compared with both London and England as a whole. Overall, in greater London, 59.8% of the population are White and 40.2% are Black, Asian, and minority ethnic (substantially higher compared to England). The proportion of white people is slightly higher in the two boroughs included in this study: Camden—66.3% and Islington—68.0%.
Table 1

Descriptive statistics for Camden & Islington, compared with statistics for London and England as a whole.

C&I catchmentComparison statistics
CamdenIslingtonLondonEngland
Total population*241,059227,6928,673,71354,786,327
Sex*M50.0%50.0%49.7%49.3%
F50.0%50.0%50.3%50.7%
Age*15–2414.4%15.4%12.0%12.4%
25–3422.9%27.9%20.4%14.3%
35–4415.7%15.2%15.7%13.0%
45–5411.7%11.6%12.9%14.1%
55–648.3%7.3%8.9%11.3%
65–746.5%4.9%6.2%9.6%
75–843.6%2.8%3.8%5.7%
85+1.6%1.0%1.6%2.4%
Ethnicity #White66.3%68.0%59.8%85.5%
Asian / Asian British16.1%9.0%18.4%7.7%
Black / Black British8.2%13.0%13.3%3.4%
Mixed5.6%6.0%5.1%2.2%
Other3.5%4.0%3.4%1.2%

* ONS 2014 mid-year population estimates (Data source: https://data.london.gov.uk/dataset/ons-mid-year-population-estimates-custom-age-tables)

# ONS 2011 census data

* ONS 2014 mid-year population estimates (Data source: https://data.london.gov.uk/dataset/ons-mid-year-population-estimates-custom-age-tables) # ONS 2011 census data C&I provide mental health and substance misuse services to people living in Camden and Islington, substance misuse services to Westminster, and a substance misuse and psychological therapies service to residents in Kingston. The Trust has two inpatient facilities, at Highgate Mental Health Centre and St Pancras Hospital, as well as community based services throughout the London boroughs of Camden and Islington. The Trust provides services for adults of working age, adults with learning difficulties, and older people in community or inpatient settings.

The C&I Research Database

Routine recording of EHRs at C&I had commenced in mid-2008 using RiO, an electronic patient record system. RiO contains a comprehensive, longitudinal record of all clinical information recorded throughout patients’ contacts with Trust services, including socio-demographic information, dates and other details of referrals and admissions, detailed clinical assessments, care plans and standardized assessment forms (such as the Risk Assessment [10] and Health of The Nation Outcome Scales [11]). The record consists of both structured fields (such as dates and pick-lists) and unstructured free text (including progress notes and correspondence). The CRIS tool, developed by SLAM BRC to extract information from their bespoke electronic Patient Journey System (PJS), consists of a series of data-processing pipelines which both structure and de-identify fields in the EHR, rendering effectively anonymized data from the full clinical record available at the researcher interface (2). The system allows researchers to search against any combination of structured and unstructured fields that exists in the database. Users then specify the precise fields they want returned (such as specific diagnostic codes, demographic information and/or a particular text string in a clinical assessment) (5). The C&I Research Database employs the same security model as that developed by SLaM to address the legal and ethical considerations attendant upon the use of confidential health data [5]. Authorized researchers are provided with regulated access to anonymized information extracted from patient EHRs. The research database is used to support epidemiological and population-based research using only anonymized data, for which no patient consent is necessary though patients can opt out entirely if they choose. Studies using the C&I Research Database received ethical approval from the NRES Committee East of England—Cambridge Central (14/EE/0177). Access to the database is overseen by an Oversight Committee including stakeholders and patient leadership. The Committee oversees approvals for researchers and studies; ensures that queries do not carry a significant potential for de-anonymization; and monitors use of the database to ensure that studies are conducted in accordance with information governance regulations. The database administrator works closely with the Oversight Committee and the Trust’s R&D division on the day to day management of the Research Database.

Data extraction from free text

Natural language processing (NLP) techniques have been developed and applied by SLAM BRC, in collaboration with University of Sheffield Department of Computer Science, for extracting knowledge from unstructured text captured in clinical notes and correspondence. The development of these techniques has been described elsewhere [2]. Several NLP applications using rule based pattern matching of key concepts have been applied to the C&I Research Database. These applications were built using General Architecture for Text Engineering (GATE), a widely used program which provides a suite of tools to assist with NLP tasks such as information extraction from clinical notes. These applications were designed to extract data from the free text taking into account the linguistic context of a word or phrase of interest, thus allowing structured data to be obtained from free text fields.

Analysis plan

Cohort profile

Descriptive statistics for the sex, age and ethnicity of all patients included in the C&I Research Database on the 31st of August 2015 were examined. Patients receiving active care were defined as those who had joined the Trust in the previous year or who had open referrals, admissions or care-plans recorded in the preceding year. The demographic characteristics of patients receiving active care were examined separately.

Time to diagnosis and initiation of treatment in patients presenting to mental health services with bipolar disorder

To assess the capabilities of the C&I Research Database and cross-site comparability we sought to replicate a study conducted by Patel et al. [12] examining time to diagnosis and treatment of bipolar disorder using the SLAM BRC case register. For this purpose, we identified a cohort of individuals meeting the following criteria from the C&I Research Database: First presentation to C&I between 1st January 2009 and 31st August 2014. Age between 16 and 65 years at first presentation. Subsequent diagnosis of mania or bipolar affective disorder before 31st August 2015. Diagnoses of mania and bipolar disorder were derived from EHR structured fields containing ICD-10 diagnoses (F30.x and F31.x). This information was then supplemented with diagnostic data retrieved from free text fields using NLP. The NLP application for ‘diagnosis’ extracts text strings associated with a diagnosis statement in order to supplement the existing structured fields. We tested the positive predictive value (PPV) of the application for extracting and coding diagnosis data on randomly selected instances where the application coded the patient as being diagnosed with bipolar disorder (n = 100). We then determined if this was correct by manually searching through the underlying document. To determine sensitivity we extracted a random set of documents (n = 100) that contained the words ‘bipolar disorder’, read these documents to ascertain whether the patient was actually diagnosed with bipolar disorder, then determined if this was in agreement with the coding performed by the NLP application. In order to ensure that participants included in the analysis had a stable diagnosis of bipolar disorder, only participants whose mania or bipolar disorder diagnosis was confirmed at least once within one year of initial diagnosis were included. The time period of 2009 to August 2014 was chosen as 2009 was the first full year in which EHRs were implemented in C&I, and to ensure that all individuals in the study had at least one year of follow-up data available. The CRIS tool was used to extract the following predictor variables from the dataset: 1) whether the patient was admitted to hospital compulsorily under the UK Mental Health Act (MHA) within 2 weeks of first presentation to C&I, and 2) whether the patient received a diagnosis of schizophrenia or related disorders (ICD-10 F2x), psychotic depression (ICD-10 F32.3/F33.3), unipolar depression without psychotic symptoms (ICD-10 F32/33 excluding F3x.3), anxiety disorder (ICD-10 F4x), personality disorder (ICD-10 F60/F61), alcohol or illicit drug misuse/dependence (ICD-10 F10.x, F11-19.x) prior to the date of first bipolar disorder diagnosis. The following variables were extracted as covariates for multivariable analyses: age, sex, ethnicity and marital status. All covariate data obtained were those closest to the time of first referral to C&I. The primary outcome variable was time to diagnosis of bipolar disorder (in days) measured from the date of first presentation to C&I. We considered this time to represent the interval to diagnosis of bipolar disorder while receiving specialist mental healthcare. The secondary outcome variable was time to first prescription of appropriate treatment (in days) measured from the date of first presentation to C&I. We considered this time to represent the interval to initiating treatment. As defined by Patel et al. [12], and in reference to the British Association of Psychopharmacology guidelines [13], appropriate pharmacological treatment included initiation of any of second generation antipsychotic, lithium, valproate, carbamazepine and lamotrigine identified using the NLP application for ‘medication’. Associations between predictor variables and time to diagnosis and treatment were investigated using Kaplan-Meier survival analysis and multivariable Cox regression. The hazard ratios in Cox regression analyses represent the probability of bipolar disorder diagnosis or initiation of treatment occurring during the period of follow-up. Therefore, a hazard ratio greater than 1.0 indicates an association of a predictor variable with reduced time to diagnosis or treatment compared to the reference category. Reference categories for Cox regression analysis were defined as those of greatest prevalence. By virtue of the study inclusion criteria, all participants were diagnosed with bipolar disorder and so no censoring was required in the survival analysis of time to diagnosis (time to first record of bipolar disorder in structured field or free text). For analysis of time to treatment, the outcome of starting appropriate treatment was censored at 31st August 2015. Data were analyzed using SPSS version 22.0 [14].

Results

Cohort profile

Table 2 shows summary statistics of C&I Research Database for the years 2008 -31st August 2015. The largest age group of patients was 35–44 years. There were slightly more females than males represented in the database. While the majority of patients were from white ethnic backgrounds, approximately a third of the patients did not have ethnicity recorded in their EHRs, making comparisons to the ethnic composition of the C&I boroughs difficult.
Table 2

Demographic characteristics of patients in the C&I Research Database.

All Patients (n = 108,168)Active patients1 (n = 23,538)
SexM52,243 (48.4%)11,726 (49.8%)
F55,718 (51.5%)11,806 (50.2%)
missing159 (0.1%)6 (0.02%)
Age15–245,302 (4.9%)2,258 (9.6%)
25–3419,854 (18.4%)4,620 (19.6%)
35–4424,665 (22.8%)4,587 (19.5%)
45–5422,295 (20.6%)4,546 (19.3%)
55–6412,725 (11.8%)2,553 (10.8%)
65–747,838 (7.2%)1,552 (6.6%)
75–846,266 (5.8%)1,842 (7.8%)
85+9,175 (8.5%)1,580 (6.7%)
EthnicityWhite51,713 (47.8%)13,560 (57.7%)
Asian / Asian British4,136 (3.8%)1,219 (5.2%)
Black / Black British7,620 (7.0%)2,539 (10.8%)
Mixed1,923 (1.8%)695 (3.0%)
Other5,737 (5.3%)1,597 (6.8%)
Missing36,991 (34.2%)3,928 (16.7%)

1 Patient receiving active care are those who had joined the Trust in the last year or who had open referrals, admissions or care-plans recorded in the last year

1 Patient receiving active care are those who had joined the Trust in the last year or who had open referrals, admissions or care-plans recorded in the last year On the 31st August 2015, the number of patients receiving active care (defined as those who had joined the Trust in the last year or who had open referrals, admissions or care-plans recorded in the last year) was 23,538. Active patients were slightly younger than the entire cohort (with a higher proportion aged 15–34), and had fewer missing data.

Time to diagnosis and initiation of treatment in patients presenting to mental health services with bipolar disorder

We identified a cohort of 467 individuals meeting the inclusion criteria for this study. A comparison of the study population identified at C&I and that identified at SLaM by Patel et al. [12] is presented in Table 3.
Table 3

Time to diagnosis and treatment of bipolar disorder—Comparison between C&I and SLaM cohorts.

C&ISLaM
Residents in catchment area470,0001,200,000
Period of first presentation to Trust1st January 2009–31st August 20141st January 2007–31st December 2012
No. of patients with bipolar disorder meeting inclusion criteria467 (0.10%)*1364 (0.11%)
No. of patients with bipolar disorder receiving appropriate treatment by end of follow-up395 (85%)#1206 (88%)
Median time to diagnosis (IQR), days76 (17–391)62 (17–243)
Median time to treatment (IQR), days37 (5–194)31 (4–122)

* Percent of residents in the catchment area who meet inclusion criteria

# Percent of patients with bipolar disorder who received appropriate treatment by the end of follow-up

* Percent of residents in the catchment area who meet inclusion criteria # Percent of patients with bipolar disorder who received appropriate treatment by the end of follow-up

Performance of NLP application for the detection of bipolar disorder

The NLP ‘diagnosis’ application was able to identify instances of bipolar disorder with high PPV, although sensitivity levels were more modest. The PPV obtained from the validation set of 100 patients was 0.92, and sensitivity was 0.64.

Time to diagnosis

The median interval to diagnosis of bipolar disorder was 76 days (IQR 17–391). Kaplan-Meier analysis illustrates the distribution of intervals to diagnosis over time (Fig 1). The interval identified at SLaM was slightly shorter (median = 62, IQR 17–243 days [12]; Table 3).
Fig 1

Kaplan-Meier plot of time to diagnosis.

Table 4 shows the breakdown of time to diagnosis according to demographic and clinical characteristics. Table 5 shows the associations between patient characteristics and time to diagnosis. As in the SLaM cohort, there were no significant associations between time to diagnosis and age, sex, ethnicity or marital status. Patients with missing data on either ethnicity or marital status had shorter intervals to diagnosis as compared to their counterparts. Prior diagnoses of other psychiatric disorders were associated with longer intervals to diagnosis compared to people without these prior diagnoses. In particular, prior diagnoses of personality disorders were associated with substantially longer median intervals to diagnosis. Compulsory admission under the UK MHA was associated with shorter interval to diagnosis.
Table 4

Time to diagnosis and treatment of bipolar disorder by demographic and clinical characteristics.

FactorGroupNumber in samplePercentageMedian Interval to diagnosis in days (IQR)Median Interval to treatment in days (IQR)*
Age (years)<2512226.1%91 (20–519)44 (8–203)
26–3516836.0%55 (14–302)45 (5–221)
36–4510823.1%74 (14–340)24 (4–188)
46–554710.1%56 (27–336)43 (4–138)
56–65224.7%164 (50–331)38 (8–216)
SexFemale27659.1%78 (17–414)45 (6–244)
Male19140.9%76 (17–386)34 (5–135)
EthnicityWhite30064.2%87 (19–502)47 (6–212)
Asian214.5%43 (2–529)26 (6–344)
Black367.7%110 (27–298)34 (8–246)
Other5511.5%28 (12–419)16 (2–160)
Not recorded5511.5%40 (11–133)35 (3–138)
Marital statusMarried/Cohabiting5912.6%141 (18–574)43 (5–331)
Divorced/Separated388.1%60 (30–211)55 (18–137)
Single28160.2%97 (21–494)44 (7–217)
Widowed20.4%--
Not recorded8718.6%22 (2–85)10 (1–112)
UK Mental Health ActCompulsory admission within 2 weeks of first presentation7015.0%11 (1–30)3 (1–8)
Prior DiagnosisSchizophrenia or related disorders408.6%414 (144–888)12 (2–177)
Psychotic depression51.1%547 (214–1136)10 (3–68)
Unipolar depression without psychotic symptoms398.4%449 (133–1028)125 (24–287)
Anxiety disorder255.4%503 (206–955)48 (4–200)
Personality disorder183.9%983 (137–1609)175 (45–702)
Alcohol / drug misuse or dependence204.3%224 (109–764)102 (7–213)

*Includes only 395 patients who received appropriate treatment during the follow-up period

Table 5

Factors associated with time to diagnosis and treatment of bipolar disorder (n = 467)—Multivariable cox regression model.

FactorGroupInterval to diagnosisInterval to treatment
*Adjusted hazard ratio95% confidence interval, p value*Adjusted hazard ratio95% confidence interval, p value
Age (years)<250.890.70–1.14,p = 0.340.860.66–1.12,p = 0.27
26–35ReferenceReference
36–451.000.78–1.29,p = 0.9960.940.72–1.23,p = 0.64
46–550.900.64–1.27,p = 0.550.860.59–1.27,p = 0.45
56–650.880.56–1.38,p = 0.571.300.80–2.11,p = 0.29
SexFemaleReferenceReference
Male0.920.95–1.12,p = 0.390.890.72–1.11,p = 0.30
EthnicityWhiteReferenceReference
Asian1.320.84–2.08,p = 0.231.230.76–2.00,p = 0.41
Black0.980.68–1.41,p = 0.900.990.67–1.47,p = 0.95
Other1.110.82–1.50,p = 0.501.150.84–1.58,p = 0.39
Not recorded1.591.15–2.20,p = 0.0051.070.75–1.52,p = 0.72
Marital statusMarried/Cohabiting0.850.63–1.16,p = 0.310.920.66–1.27,p = 0.60
Divorced/Separated1.110.77–1.58,p = 0.581.150.79–1.67,p = 0.48
SingleReferenceReference
Widowed2.310.55–9.59,p = 0.252.020.48–8.46,p = 0.34
Not recorded1.581.20–2.08,p = 0.0010.910.67–1.23,p = 0.53
UK Mental Health ActCompulsory admission within 2 weeks of first presentation3.922.90–5.30,p < .0014.032.98–5.47,p < .001
Prior DiagnosisSchizophrenia or related disorders0.400.27–0.57,p < .0011.521.05–2.20,P = 0.025
Psychotic depression0.800.32–2.00,p = 0.642.310.86–6.23,p = 0.097
Unipolar depression without psychotic symptoms0.640.45–0.91,p = 0.010.900.62–1.32,p = 0.59
Anxiety disorder0.590.39–0.91,p = 0.021.150.72–1.82,p = 0.56
Personality disorder0.410.24–0.68,p = 0.0010.800.47–1.36,p = 0.42
Alcohol / drug misuse or dependence0.890.55–1.41,p = 0.591.120.67–1.89,p = 0.67

*Model adjusted for all factors listed in this table

*Includes only 395 patients who received appropriate treatment during the follow-up period *Model adjusted for all factors listed in this table

Time to treatment

Of the 467 individuals included in this study, 395 received appropriate treatment prior to 31st August 2015. The median interval to treatment was 37 days (IQR 5–194), comparable to that found at SLaM (median = 31, IQR 4–122 days [12]; Table 3). 196 individuals (54.6%) were found to have shorter time to treatment than time to diagnosis. Kaplan-Meier analysis illustrates the distribution of intervals to treatment over time (Fig 2).
Fig 2

Kaplan-Meier plot of time to treatment.

Time to Treatment by demographic and clinical characteristics is presented in Table 4, and the associations between these characteristics and time to treatment is presented in Table 5. As in the SLaM cohort, there were no significant associations between time to treatment and age, sex, ethnicity or marital status. In contrast to time to diagnosis, prior diagnoses of schizophrenia and related disorders were significantly associated with a reduction in median interval to treatment. Compulsory admission under the UK MHA was associated with shorter interval to treatment.

Discussion

This paper describes the properties of a psychiatric case register containing fully EHRs from a large UK secondary mental healthcare provider. The case register is an effective data source for studying patterns of care, providing invaluable information for evaluating/auditing and planning services, as well as monitoring service use [5]. The information can be retrieved in a much quicker and more efficient fashion than more traditional methods of record keeping. Currently, the C&I Research Database contains over 108,000 patient records. The database is routinely updated, cleaned and anonymized, enabling users to search and extract anonymized data. The strengths of the database lie in its size, breadth, long-term follow-up, and representativeness of the population in the two boroughs (in the UK the vast majority of mental healthcare is provided by specific state-run services with minimal use of privately funded care). The limitations stem from the fact that these are routinely collected health records rather than data collected specifically for research purposes. Information incompleteness, inaccuracy, and inconsistency are challenges, and data quality is largely dependent on the healthcare professionals who record the clinical information. Many patients accessing secondary mental healthcare will receive diagnosis and treatment in primary care. Additional information relating to patients’ morbidity and mortality may not be available within mental health EHRs but rather stored in external databases. Thus, future plans for the C&I Research Database include linkage with external data sources. SLaM’s experience with data linkages (2) suggests that it has the potential to enhance existing data and expand the depth of information available in mental health case registers. However, data linkage also poses several challenges including different regulatory processes across each of the data providers, mismatched identifier variables which may limit the linkage process, and the sheer volume of data to be processed. Much of the clinical information in EHRs is recorded in free text fields. Free text is often richer in detail but requires specialized approaches, including NLP, to extract clinically relevant concepts [15]. Such techniques have been applied in the C&I Research Database enabling the retrieval of information from free text. In the context of this paper we evaluated the performance of an NLP application designed to extract diagnoses from free text fields. The diagnosis of bipolar disorder showed high PPV and moderate sensitivity. Employing text mining within this data set has involved a trade-off between PPV and sensitivity. However, the longitudinal nature of EHR data means that there are generally multiple opportunities for an NLP application to capture a piece of information; therefore, suboptimal sensitivity can be compensated for and the focus has been on maximising PPV [2]. Next, to illustrate the capabilities of the C&I Research Database, we investigated time to diagnosis and treatment of bipolar disorder from initiation of specialist mental healthcare. The median interval to diagnosis from the point of receiving specialist mental healthcare was slightly longer at C&I compared to SLaM [12] with a wider distribution, partially due to the smaller sample size. A similar trend was observed for the interval to receiving appropriate treatment for bipolar disorder. As suggested by Patel et al [12], the fact that time to treatment was shorter than time to diagnosis for the majority of patients may reflect the initiation of treatment by clinicians prior to recording a formal diagnosis of bipolar disorder in the EHR. It is important to note that it was not possible to determine whether first contact with specialist mental healthcare was based on presenting bipolar symptoms for the index diagnostic episode or for other/ pre-existing mental health problems. The distinction between these may have implications on time to diagnosis and treatment. Similar to the results using the SLaM case register, we found no significant association of age, sex, ethnicity or marital status with time to diagnosis or treatment. Patients who underwent compulsory admission to hospital under the UK MHA had a shorter interval to diagnosis and treatment. Admission under the UK MHA may be a marker of illness severity, requiring prompt treatment and facilitating a more timely diagnosis. Prior diagnoses of other psychiatric disorders were associated, for the most part, with longer time to diagnosis, particularly in the case of prior diagnoses of personality disorders. It is possible that early symptoms of bipolar disorder are often misattributed to other psychiatric conditions. This is in line with the finding of the National Depressive and Manic-Depressive Association reporting that many patients with bipolar disorder are misdiagnosed initially [16], and the evidence of high comorbidity of bipolar disorder with other psychiatric diagnoses [17]. Contrary to this, prior diagnoses of schizophrenia and related disorders were significantly associated with a reduction in median interval to treatment. This could be explained by the use of second generation antipsychotics to treat psychotic disorders (which are also indicated in the treatment of bipolar disorder); hence, the increased time to diagnosis is not reflected in a parallel increased time to treatment. In summary, this paper aimed to describe the C&I Research Database and demonstrate its capabilities. While the C&I Research Database contains data from a single mental healthcare provider in a geographical catchment area, results are similar to those observed in SLaM—a mental healthcare provider covering a much larger catchment area with a diverse population. It is reassuring that data from different organizations deliver similar results, and that NLP applications developed in one Trust can then be successfully deployed in another. It is also encouraging that the CRIS tool which was developed to extract data from SLaM’s bespoke EHR system—PJS—worked equally well on a different EHR system, namely RiO. The findings support the secondary use of EHRs for large-scale research in mental health. Such data can enable new insights into mental health processes and outcomes investigated across large, diverse geographical areas, answering questions of regional, national and international importance.
  13 in total

1.  The goals and limitations of Israel's psychiatric case register.

Authors:  P Lichtenberg; Z Kaplan; A Grinshpoon; D Feldman; D Nahon
Journal:  Psychiatr Serv       Date:  1999-08       Impact factor: 3.084

2.  Clinical risk assessment rating and all-cause mortality in secondary mental healthcare: the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) Case Register.

Authors:  C Y Wu; C K Chang; R D Hayes; M Broadbent; M Hotopf; R Stewart
Journal:  Psychol Med       Date:  2011-12-08       Impact factor: 7.723

3.  Toward a national framework for the secondary use of health data: an American Medical Informatics Association White Paper.

Authors:  Charles Safran; Meryl Bloomrosen; W Edward Hammond; Steven Labkoff; Suzanne Markel-Fox; Paul C Tang; Don E Detmer
Journal:  J Am Med Inform Assoc       Date:  2006-10-31       Impact factor: 4.497

4.  Misdiagnosis of bipolar disorder.

Authors:  Tanvir Singh; Muhammad Rajput
Journal:  Psychiatry (Edgmont)       Date:  2006-10

5.  Health of the Nation Outcome Scales (HoNOS). Research and development.

Authors:  J K Wing; A S Beevor; R H Curtis; S B Park; S Hadden; A Burns
Journal:  Br J Psychiatry       Date:  1998-01       Impact factor: 9.319

6.  Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology.

Authors:  G M Goodwin
Journal:  J Psychopharmacol       Date:  2009-03-27       Impact factor: 4.153

Review 7.  Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research.

Authors:  Nicole Gray Weiskopf; Chunhua Weng
Journal:  J Am Med Inform Assoc       Date:  2012-06-25       Impact factor: 4.497

8.  Delays before Diagnosis and Initiation of Treatment in Patients Presenting to Mental Health Services with Bipolar Disorder.

Authors:  Rashmi Patel; Hitesh Shetty; Richard Jackson; Matthew Broadbent; Robert Stewart; Jane Boydell; Philip McGuire; Matthew Taylor
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

9.  Development and evaluation of a de-identification procedure for a case register sourced from mental health electronic records.

Authors:  Andrea C Fernandes; Danielle Cloete; Matthew T M Broadbent; Richard D Hayes; Chin-Kuo Chang; Richard G Jackson; Angus Roberts; Jason Tsang; Murat Soncul; Jennifer Liebscher; Robert Stewart; Felicity Callard
Journal:  BMC Med Inform Decis Mak       Date:  2013-07-11       Impact factor: 2.796

10.  Cohort profile of the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLaM BRC) Case Register: current status and recent enhancement of an Electronic Mental Health Record-derived data resource.

Authors:  Gayan Perera; Matthew Broadbent; Felicity Callard; Chin-Kuo Chang; Johnny Downs; Rina Dutta; Andrea Fernandes; Richard D Hayes; Max Henderson; Richard Jackson; Amelia Jewell; Giouliana Kadra; Ryan Little; Megan Pritchard; Hitesh Shetty; Alex Tulloch; Robert Stewart
Journal:  BMJ Open       Date:  2016-03-01       Impact factor: 2.692

View more
  10 in total

1.  Real-World Clinical Outcomes Two Years After Transition to Psychosis in Individuals at Clinical High Risk: Electronic Health Record Cohort Study.

Authors:  Paolo Fusar-Poli; Andrea De Micheli; Rashmi Patel; Lorenzo Signorini; Syed Miah; Thomas Spencer; Philip McGuire
Journal:  Schizophr Bull       Date:  2020-04-18       Impact factor: 9.306

2.  NeuroBlu, an electronic health record (EHR) trusted research environment (TRE) to support mental healthcare analytics with real-world data.

Authors:  Rashmi Patel; Soon Nan Wee; Rajagopalan Ramaswamy; Simran Thadani; Jesisca Tandi; Ruchir Garg; Nathan Calvanese; Matthew Valko; A John Rush; Miguel E Rentería; Joydeep Sarkar; Scott H Kollins
Journal:  BMJ Open       Date:  2022-04-22       Impact factor: 3.006

3.  Mental health-related conversations on social media and crisis episodes: a time-series regression analysis.

Authors:  Anna Kolliakou; Ioannis Bakolis; David Chandran; Leon Derczynski; Nomi Werbeloff; David P J Osborn; Kalina Bontcheva; Robert Stewart
Journal:  Sci Rep       Date:  2020-02-06       Impact factor: 4.379

4.  The side effect profile of Clozapine in real world data of three large mental health hospitals.

Authors:  Ehtesham Iqbal; Risha Govind; Alvin Romero; Olubanke Dzahini; Matthew Broadbent; Robert Stewart; Tanya Smith; Chi-Hun Kim; Nomi Werbeloff; James H MacCabe; Richard J B Dobson; Zina M Ibrahim
Journal:  PLoS One       Date:  2020-12-08       Impact factor: 3.240

Review 5.  Reviewing a Decade of Research Into Suicide and Related Behaviour Using the South London and Maudsley NHS Foundation Trust Clinical Record Interactive Search (CRIS) System.

Authors:  André Bittar; Sumithra Velupillai; Johnny Downs; Rosemary Sedgwick; Rina Dutta
Journal:  Front Psychiatry       Date:  2020-11-27       Impact factor: 4.157

6.  Risk factors for in-patient admission among adults with intellectual disability and autism: investigation of electronic clinical records.

Authors:  Rory Sheehan; Jennifer Mutch; Louise Marston; David Osborn; Angela Hassiotis
Journal:  BJPsych Open       Date:  2020-12-01

7.  Psychosis Relapse Prediction Leveraging Electronic Health Records Data and Natural Language Processing Enrichment Methods.

Authors:  Dong Yun Lee; Chungsoo Kim; Seongwon Lee; Sang Joon Son; Sun-Mi Cho; Yong Hyuk Cho; Jaegyun Lim; Rae Woong Park
Journal:  Front Psychiatry       Date:  2022-04-05       Impact factor: 5.435

8.  Using de-identified electronic health records to research mental health supported housing services: A feasibility study.

Authors:  Christian Dalton-Locke; Johan H Thygesen; Nomi Werbeloff; David Osborn; Helen Killaspy
Journal:  PLoS One       Date:  2020-08-20       Impact factor: 3.240

9.  Dementia severity at death: a register-based cohort study.

Authors:  Jesutofunmi Aworinde; Nomi Werbeloff; Gemma Lewis; Gill Livingston; Andrew Sommerlad
Journal:  BMC Psychiatry       Date:  2018-11-01       Impact factor: 3.630

10.  Cognitive neuropsychiatric analysis of an additional large Capgras delusion case series.

Authors:  Emily A Currell; Nomi Werbeloff; Joseph F Hayes; Vaughan Bell
Journal:  Cogn Neuropsychiatry       Date:  2019-02-22       Impact factor: 1.871

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.